Megan Tones

Megan Tones is an academic affiliated with Queensland University of Technology, specializing in interdisciplinary research at the intersection of health, education, and disability studies. Her work focuses on neurodevelopmental disorders such as Angelman Syndrome and autism spectrum conditions, with significant contributions to understanding caregiver impacts, sleep disturbances in pediatric populations, and inclusive education policies. She has led and contributed to global initiatives like the Global Angelman Syndrome Registry, emphasizing multilingual accessibility and culturally responsive approaches in healthcare and education.

• Doctorate: PhD in Workplace Learning Patterns from Queensland University of Technology (2009)
• Key Research Areas: Rare disease epidemiology, educational inclusion strategies, workplace learning dynamics
• Geographic Focus: Australia, Pacific Islands, and international contexts

Her research bridges clinical observations with educational policy, particularly in marginalized communities. Recent work highlights tele-classroom consulting for remote autism support and culturally informed disability policy in the Solomon Islands. She collaborates across disciplines including medicine, education, and public health, publishing extensively on behavioral profiles, caregiver economics, and global registry systems.

Publications since 2016 reflect a sustained focus on Angelman Syndrome clinical features, sleep behavior correlations, and disability-inclusive education frameworks. Her work emphasizes participatory approaches involving parents, educators, and healthcare professionals to address systemic challenges in neurodevelopmental disorder management.

Grants & Partnerships: Involved in multi-institutional projects funded by organizations like Autism CRC and Cooperative Research Centres. Projects include the Middle Years Behaviour Support Project and Stronger Smarter Learning Communities initiative.

Labs/Teams: Collaborates with global registries and cross-sectoral teams focused on rare diseases and educational equity.